Search Tag: Tyra Biosciences

Executive Health Management

Tyra Biosciences Announces Planned Chief Financial Officer Transition

2022 02 Nov

- Esther van den Boom  to transition to an advisor at year-end 2022- - Alan Fuhrman  to be named Chief Financial Officer- Tyra Biosciences, Inc, a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer announced that its Chief Financial Officer, ... Read more